A hopeful therapy for Niemann-Pick C diseases - The Lancet
Por um escritor misterioso
Descrição
Targeting the central nervous system in lysosomal storage diseases
Pharmaceuticals, Free Full-Text
Enzyme-replacement therapy for metabolic storage disorders - The
Identification of Niemann-Pick C1 disease biomarkers through
Lysosomal storage disorders: from biology to the clinic with
Improved systemic AAV gene therapy with a neurotrophic capsid in
Full article: Current advancements in therapy for Niemann-Pick
Marta, with Niemann Pick C, fights for a cure with gene therapy
Intrathecal 2-hydroxypropyl-β-cyclodextrin decreases neurological
The Lancet Infectious Diseases Home Page
Miglustat in Niemann-Pick disease type C patients: a review
Effects of miglustat therapy on neurological disorder and survival
Enzyme therapy is not enough - The Lancet
Niemann–Pick Disease Type C1
A first therapy for Niemann-Pick C - The Lancet Neurology
de
por adulto (o preço varia de acordo com o tamanho do grupo)
